Last edition
News about
Pfizer inks deal to acquire Abzena's manufacturing plant in North Carolina
Construction is ongoing at the location, which Abzena selected back in April 2021 for its access to a talented workforce and other resources
Lonza completes expansion at Oregon site
The project included the remodelling of laboratory space used to develop early-stage compounds
Strides Pharma's Bengaluru facility receives EIR from US FDA
The abbreviated Quality System Inspection Technique (QSIT) drug pre-approval on-site inspection was specifically conducted by the US FDA
Sai Life Sciences opens high-potency API manufacturing facility at Bidar Campus
The facility is spread across 16000 sq ft HPAPI block
Celadon Pharma's UK-based facility bags GMP registration by MHRA
Celadon's medicinal cannabis product will be supplied in oil form as an API
Lupin gets two observations from US FDA for Somerset facility
The inspection closed with the issuance of a Form-483 with two observations
Eurofins CDMO Alphora expands API development labs
The 56,000-square foot building is the new home of Eurofins CDMO Alphora’s API process R&D activity, solid-state R&D activity and its analytical services team
Dr Reddy's acquires trademark rights of breast cancer drug PRIMCYV from Pfizer Products India
Following the trademark rights acquisition, Dr Reddy’s will manufacture the Active Pharmaceutical Ingredient (API) and finished drug at its state-of-the-art facilities
Piramal Pharma's Lexington facility gets six observations from US FDA
The observations were classified under VAI (Voluntary Action Indicated) and do not relate to data integrity<br />
Australia-headquartered Novotech to acquire EastHORN
The acquisition is part of Novotech's global expansion programme
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy